Drug intelligence / Profile preview

VitaZynq

Development stage: Preclinical
Lead developer: DanCann Pharma
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

VitaZynq (also known as OTC01) is a full-spectrum botanical extract derived from *Cannabis sativa L.*, currently under development by DanCann Pharma. As a full-spectrum phyto-extract, it is designed to retain the comprehensive profile of cannabinoids, terpenes, and flavonoids naturally occurring in the cannabis plant, potentially leveraging the entourage effect for enhanced therapeutic benefit. The product is specifically positioned for the over-the-counter (OTC) market, targeting general health and wellness applications rather than prescription-only medical indications. It is currently in the development phase as part of DanCann Pharma's OTC product pipeline.

Brand names: VitaZynq
Other names: VitaZynq OTC01

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on VitaZynq.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VitaZynq.

Explore the full profile